[PDF][PDF] The tumor suppressor Smad4/DPC4 is regulated by phosphorylations that integrate FGF, Wnt, and TGF-β signaling

H Demagny, T Araki, EM De Robertis - Cell reports, 2014 - cell.com
H Demagny, T Araki, EM De Robertis
Cell reports, 2014cell.com
Smad4 is a major tumor suppressor currently thought to function constitutively in the
transforming growth factor β (TGF-β)-signaling pathway. Here, we report that Smad4 activity
is directly regulated by the Wnt and fibroblast growth factor (FGF) pathways through GSK3
and mitogen-activated protein kinase (MAPK) phosphorylation sites. FGF activates MAPK,
which primes three sequential GSK3 phosphorylations that generate a Wnt-regulated
phosphodegron bound by the ubiquitin E3 ligase β-TrCP. In the presence of FGF, Wnt …
Summary
Smad4 is a major tumor suppressor currently thought to function constitutively in the transforming growth factor β (TGF-β)-signaling pathway. Here, we report that Smad4 activity is directly regulated by the Wnt and fibroblast growth factor (FGF) pathways through GSK3 and mitogen-activated protein kinase (MAPK) phosphorylation sites. FGF activates MAPK, which primes three sequential GSK3 phosphorylations that generate a Wnt-regulated phosphodegron bound by the ubiquitin E3 ligase β-TrCP. In the presence of FGF, Wnt potentiates TGF-β signaling by preventing Smad4 GSK3 phosphorylations that inhibit a transcriptional activation domain located in the linker region. When MAPK is not activated, the Wnt and TGF-β signaling pathways remain insulated from each other. In Xenopus embryos, these Smad4 phosphorylations regulate germ-layer specification and Spemann organizer formation. The results show that three major signaling pathways critical in development and cancer are integrated at the level of Smad4.
cell.com